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Abstract: We aimed to assess postprandial metabolic and appetite responses to a mixed-18 
macronutrient lunch following prior addition of whey protein to a carbohydrate-rich breakfast. Ten 19 
healthy males (age: 24 ± 1 y; body mass index (BMI): 24.5 ± 0.7 kg/m2) completed three trials in a 20 
non-isocaloric, crossover design. A carbohydrate-rich breakfast (93 g carbohydrate; 1799 kJ) was 21 
consumed with (CHO+WP) or without (CHO) 20 g whey protein isolate (373 kJ), or breakfast was 22 
omitted (NB). At 180 minutes, participants consumed a mixed-macronutrient lunch meal. Venous 23 
blood was sampled at 15 minute intervals following each meal and every 30 minutes thereafter, 24 
while subjective appetite sensations were collected every 30 minutes throughout. Post-breakfast 25 
insulinaemia was greater after CHO+WP (time-averaged area under the curve (AUC0-180 min): 193.1 ± 26 
26.3 pmol/L), compared to CHO (154.7 ± 18.5 pmol/L) and NB (46.1 ± 8.0 pmol/L; p < 0.05), with no 27 
difference in post breakfast (0-180 min) glycaemia (CHO+WP, 3.8 ± 0.2 mmol/L; CHO, 4.2 ± 0.2 28 
mmol/L; NB, 4.2 ± 0.1 mmol/L; p = 0.247). There were no post lunch (0-180 min) effects of condition 29 
on glycaemia (p = 0.492), insulinaemia (p = 0.338) or subjective appetite (p > 0.05). Adding whey 30 
protein to a carbohydrate-rich breakfast enhanced the acute postprandial insulin response, without 31 
influencing metabolic or appetite responses following a subsequent mixed-macronutrient meal.  32 
Keywords: Whey protein; appetite; breakfast; glycaemia; insulinaemia 33 
 34 
1. Introduction 35 
There is a growing body of evidence implicating manipulation of meal macronutrient content, in 36 
particular protein ingestion, on markers of metabolic health (for review see [1]). The postprandial 37 
effects of dairy protein have been investigated extensively [2,3], and recent studies point to whey 38 
protein in particular as having potentially advantageous effects such as reduced postprandial 39 
glycaemia [4,5] and lipaemia [6], potentially mediated by an increased postprandial insulin response 40 
[7,8]. Recent studies also suggest whey protein may induce potentially beneficial effects on appetite 41 
[9,10]. Despite the predominant use of fasting markers to determine disease risk in the clinical setting, 42 
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the importance of the postprandial milieu including hyperglycaemia [11] and hyperlipidaemia [12] is 43 
increasingly being recognised as an important indicator of cardiovascular disease risk [13]. Thus the 44 
use of sequential meal testing in individuals has a clear clinical utility, particularly with regards to 45 
triglyceride metabolism [14]. 46 
Ingestion of whey protein has been shown to promote insulin secretion to a greater extent than 47 
other proteins sources [15] in lean individuals, with a high concentration of branched-chain amino 48 
acids, particularly leucine, and their fast rate of appearance as likely integral mediators [16,17]. The 49 
subsequent synthesis and secretion of the incretin hormones glucose-dependent insulinotrophic 50 
polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) in healthy subjects, due to the presence of 51 
amino acids and peptides derived from whey protein digestion [18], also likely play an important role 52 
in enhanced insulinaemic response. Incretin hormones increase both fasting and postprandial insulin 53 
release [19] and their presence, in concert with increased plasma insulin concentrations, may also lead 54 
to appetite suppressive effects [20].  55 
A number of studies have investigated the effects of whey protein when consumed prior to, or 56 
alongside, a meal on postprandial glycaemia in normal-weight [15,21], overweight [9] or diabetic 57 
populations [22]. When whey protein (18.2 g) is ingested at the same time as a high glycaemic index 58 
lunch meal, a 21% reduction in glucose area under the curve (AUC) has been identified in type 2 59 
diabetes patients [5]. A dose-dependent reduction in glucose AUC has also been shown in healthy 60 
individuals [23]. Following consumption of whey protein 30 minutes prior to a meal, reductions in 61 
glycaemia have also been shown in healthy participants [4] and type 2 diabetes patients [24]. 62 
However, the application of these data is reduced as the consumption of a preload approximately 30 63 
minutes prior to a meal does not necessarily reflect conventional eating habits of the free-living 64 
individual [25].  65 
Studies have also regularly prescribed large doses of whey protein which may not be practical to 66 
consume and involve intake of relatively high amounts of additional energy; typically, doses of up to 67 
55 g [22] have been employed. Furthermore, these studies typically involve short observation periods 68 
[26] and the observation of single meal responses [27]. The influence on subsequent feeding and 69 
metabolism is also important to understand as the macronutrient composition of a breakfast meal has 70 
been demonstrated to influence the glycaemic response following subsequent feeding [28] in healthy 71 
individuals. Thus, investigating the potential second meal effects of whey protein inclusion on 72 
glycaemia, insulinaemia, lipaemia and appetite may be important in identifying efficacious strategies 73 
to prevent potential declines in metabolic health, while providing further insights into the 74 
supplemental use of whey protein. 75 
Therefore, the aim of this study was to determine the acute postprandial metabolic and appetite 76 
responses following a carbohydrate-rich breakfast, with and without co-ingestion of whey protein, in 77 
addition to responses following subsequent feeding. 78 
 79 
2. Methods 80 
2.1 Participants 81 
 82 
Ten normal-weight male participants, free from metabolic disease, were recruited (mean ± SEM; 83 
age: 24 ± 1 y; mass: 79.7 ± 1.2 kg; stature: 1.81 ± 0.02 m; body mass index (BMI): 24.5 ± 0.7 kg/m2). 84 
Inclusion criteria included being recreationally active (>30 minutes of structured exercise, 5 85 
times/week) and aged 18-40 years. Participants were not eligible if they were taking medication or 86 
had a history of metabolic disease, disordered eating or smoking. All participants provided written 87 
informed consent prior to inclusion and all procedures were approved by the Faculty of Health and 88 
Life Sciences Research Ethics Committee, Northumbria University (Newcastle upon Tyne, United 89 
Kingdom) in accordance with the Declaration of Helsinki. This trial was registered at clinicaltrials.gov 90 
as NCT02414061. 91 
 92 
2.2 Experimental Design 93 
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A crossover design was implemented with three experimental conditions consisting of a 95 
carbohydrate breakfast trial (CHO), a carbohydrate breakfast with added whey protein trial 96 
(CHO+WP) and a no breakfast trial (NB). Participants attended the laboratory on three separate 97 
occasions, separated by at least 72 hours, and underwent all three conditions in random order. Prior 98 
to each visit, dietary intake was controlled through provision of a meal which participants were 99 
instructed to consume 12 hours before arrival at the laboratory. This meal provided 1.0, 0.4 and 0.5 100 
g/kg body mass of carbohydrate, fat and protein respectively (3171 kJ). Participants were also 101 
instructed to avoid strenuous physical activity and to refrain from alcohol and caffeine consumption 102 
for 24 hours prior to each visit.  103 
Upon arrival at ~0800 hours, a cannula was inserted into an antecubital vein and a baseline blood 104 
sample collected (refer to 2.4 Blood Sampling and Analysis). Visual analogue scales (VAS) were also 105 
completed in order to assess appetite sensations at baseline (see 2.5 Subjective Ratings). Participants 106 
subsequently consumed one of two test breakfasts (CHO or CHO+WP) or ingested a reference bolus 107 
of water (NB) and remained in a rested state. Postprandial blood samples were collected at 15 minute 108 
intervals for the first hour and every 30 minutes thereafter, while VAS were taken every 30 minutes 109 
throughout. After 180 minutes, participants were provided with the same standardised composite 110 
lunch meal under all conditions. Blood samples and VAS were subsequently collected at 111 
corresponding time points to the post breakfast samples (Figure 1). 112 
 113 
 114 
 115 
Figure 1. Schematic layout of experimental trials. CHO: high carbohydrate breakfast trial; CHO+WP: high-116 
carbohydrate breakfast with added whey protein trial; NB: no breakfast trial. 117 
 118 
2.3 Test Meals 119 
 120 
The energy content and macronutrient composition of the test meals provided during each trial 121 
are displayed in Table 1. The breakfast meal given under CHO and CHO+WP consisted of white 122 
wheat bread (95 g) and strawberry jam (48 g) with an orange juice beverage (200 ml) providing 1.2 g 123 
available carbohydrate/kg body mass (Table 1). In an effort to blind participants to the CHO and 124 
CHO+WP trials 250 ml water was provided in an opaque bottle and flavoured with 10 drops 125 
(approximately 0.5 ml) of energy free vanilla flavouring under CHO. This process was repeated for 126 
the preparation of breakfast under CHO+WP, where an identical breakfast was provided albeit with 127 
the addition of 24 g whey protein isolate, which was dissolved in the flavoured water. These 128 
beverages were therefore matched in terms of flavour, however the difference in the consistency of 129 
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the liquid due to the presence of the protein was not able to be accounted for. Participants may have 130 
been able to distinguish between these beverages, however no reference was made to which trial was 131 
being conducted throughout. The whey protein powder (Arla Foods Ingredients Group, Viby, 132 
Denmark) had a protein content of 83%, providing 20 g protein per serving which has previously 133 
been identified as an efficacious dose for reducing glycaemia [4]. The relative protein content of the 134 
CHO+WP breakfast was 0.4 g/kg body mass in comparison to 0.1 g/kg body mass under CHO. Water 135 
was also provided alongside breakfast, the volume of which was trial-dependent in order to 136 
standardise meal volumes across conditions. Under NB, a breakfast meal was not provided, however 137 
an isovolumetric bolus (675 ml) of water was consumed by participants at the applicable time point. 138 
Further water was not administered during the postprandial period in order to maintain this 139 
standardisation and control for any potential effects of meal volume on appetite suppression. A timer 140 
was started upon initiation of consumption in all trials, and participants were encouraged to consume 141 
the meal within five minutes. 142 
An identical lunch meal was served at 180 minutes post breakfast in all conditions. This consisted 143 
of a standard portion of pasta (125 g) which was cooked and added to a tomato-based sauce (170 g) 144 
along with cheddar cheese (40 g) and olive oil (15 ml) to provide 1.3, 0.4 and 0.4 g/kg body mass of 145 
carbohydrate, fat and protein respectively. Water (350 ml) was also served alongside the lunch meal, 146 
and was withheld in the post lunch period. 147 
 148 
Table 1. Energy and macronutrient composition of breakfast and lunch test meals. 149 
  
Energy 
kJ (kcal) 
Carbohydrate 
g (E%) 
Fat 
g (E%) 
Protein 
g (E%) 
 CHO 1799 (430)   93 (87)   2 (4)   9 (8) 
Breakfast CHO+WP 2172 (519)   95 (74)   2 (3) 29 (22) 
 NB       0 (0)     0 (0)   0 (0)   0 (0) 
Lunch  3446 (824) 104 (50) 33 (36) 29 (14) 
E%: percentage of total meal energy; CHO: high carbohydrate breakfast trial; CHO+WP: high-150 
carbohydrate breakfast with added whey protein trial; NB: no breakfast trial. 151 
 152 
 153 
2.4 Blood Sampling and Analysis 154 
 155 
At each collection point, a 10 ml sample of whole blood was drawn into a syringe from an 156 
intravenous cannula (Venflon, BD Becton Dickinson Ltd., New Jersey, USA). A 20 µl capillary tube 157 
was filled with whole blood for immediate determination of glucose concentration by an automated 158 
analyser (Biosen C_line, EKF Diagnostics, Cardiff, UK), while the remaining blood was transferred 159 
into an Ethylenediaminetetraacetic acid (EDTA) tube (Vacutainer®, BD Becton Dickinson Ltd., New 160 
Jersey, USA) and centrifuged (10 minutes, 1734 x g, 4˚C). Plasma aliquots were stored at -80˚C for 161 
subsequent analysis. Following collection of each sample, the cannula was kept patent through 162 
infusion of saline solution. Plasma insulin concentration was analysed using a commercially available 163 
enzyme-linked immunosorbent assay (ELISA) kit (IBL International, Hamburg, Germany), while 164 
triglyceride, non-esterified fatty acid (NEFA) and glycerol concentrations were determined using 165 
enzymatic colorimetric assays (Randox Laboratories, County Antrim, UK). Intra-assay coefficients of 166 
variation (CV) were <10% for all biochemical analyses.  167 
 168 
2.5 Subjective Ratings 169 
 170 
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Subjective appetite ratings were recorded at baseline and at 30 minute intervals following both 171 
breakfast and lunch meals using 100 mm paper-based VAS which has been validated previously [29]. 172 
Scales were used to assess hunger, fullness, satisfaction and prospective food consumption, and were 173 
anchored with extreme statements of opposite meaning at each end i.e. “not at all full” and “totally 174 
full”.  175 
 176 
2.6 Statistical Analysis 177 
 178 
Subjective appetite scales were measured from the extreme left of the scale to the point where the 179 
participant had marked, in order to give a score in mm. All VAS were measured independently by 180 
two researchers with the mean score used in all subsequent analysis. Values for hunger, fullness, 181 
prospective consumption and satisfaction were used to calculate a combined appetite score by 182 
applying Equation 1 as used previously [30]:  183 
 184 
combined appetite score =
hunger+prospective consumption+(100−fullness)+(100−satisfaction) 
4
              (1) 185 
 186 
Time-averaged AUC data for the component aspects of subjective appetite were reported alongside 187 
this composite measure.  188 
AUC values were calculated for subjective appetite and blood analyte data using the trapezoidal 189 
method for the post breakfast (0-180 min) and post lunch (180-360 min) periods [31], and these values 190 
were subsequently time-averaged. Statistical analysis was conducted using the Statistical Package for 191 
the Social Sciences (IBM SPSS; Version 21, USA). Baseline comparisons between trials and AUC for all 192 
variables were assessed using one-way repeated measures analysis of variance (ANOVA). The time 193 
point at 180 minutes post breakfast was used as the baseline value for the post lunch period. For 194 
combined appetite score, data were presented as change from baseline, with subsequent calculation of 195 
net incremental AUC (iAUC) [32]. Two-way repeated measures ANOVA (condition x time) was used 196 
to test for differences between plasma and appetite variables over time. Simple effects analysis was 197 
performed upon identification of a significant interaction effect, and the Bonferroni post-hoc test was 198 
used to correct the level of alpha for multiple comparisons. The level of statistical significance was set 199 
at p < 0.05 and data are presented as mean ± SEM.  200 
 201 
3. Results 202 
3.1 Post Breakfast Responses 203 
 204 
Baseline measures for all variables were not different between trials (p > 0.05; Figures 2-4). Post 205 
breakfast plasma insulin concentrations are displayed in Figure 2a. There was a significant condition 206 
x time interaction (p < 0.001), condition effect (p < 0.001) and time effect (p < 0.001). Concentrations 207 
peaked 30 minutes after breakfast consumption under CHO+WP and CHO, with both similarly 208 
elevated above NB (p < 0.05) at 15-120 minutes post breakfast, before returning to baseline levels. 209 
Insulinaemia across this period was greater under CHO+WP than CHO (time-averaged AUC0-180 min: 210 
CHO+WP, 193.1 ± 26.3 pmol/L; CHO, 154.7 ± 18.5 pmol/L; p = 0.033), and was greater under both 211 
breakfast trials than NB (46.1 ± 8.0 pmol/L; p < 0.001; Table 2). 212 
There was a significant condition x time interaction (p < 0.001) and significant time effect (p < 0.001) 213 
for blood glucose concentrations following breakfast consumption. Concentrations peaked similarly 214 
30 minutes after both breakfast meals (Figure 2b), with no change observed under NB (p > 0.05). Blood 215 
glucose concentrations were not different between trials at 45-180 minutes post breakfast (Figure 2b). 216 
Furthermore, there were no differences in glycaemia between conditions across the postprandial 217 
period (Time-averaged AUC0-180 min : CHO+WP, 3.8 ± 0.2 mmol/L; CHO, 4.2 ± 0.2 mmol/L; NB, 4.2 ± 0.1 218 
mmol/L; p = 0.247; Table 2). 219 
 220 
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 222 
Figure 2. Mean ± SEM temporal changes in plasma insulin (a) and blood glucose (b) during the post breakfast 223 
period, and plasma insulin (c) and blood glucose (d) during the post lunch period. Significant differences (p < 224 
0.05) between trials at individual time points are defined as follows; *NB vs CHO+WP and CHO, ** NB vs 225 
CHO, ***NB vs CHO+WP. CHO: high carbohydrate breakfast trial; CHO+WP: high-carbohydrate breakfast with 226 
added whey protein trial; NB: no breakfast trial. 227 
 228 
Plasma concentrations of triglyceride, NEFA and glycerol are presented in Figure 3. Triglyceride 229 
responses were not different between trials across the postprandial period following breakfast 230 
consumption (p > 0.05). NEFA concentrations were suppressed under CHO+WP and CHO in 231 
comparison to NB at 90-180 minutes post breakfast (p < 0.05), while glycerol was significantly lower 232 
following CHO+WP than NB at 90-120 minutes post breakfast (p < 0.05). NEFA time-averaged AUC0-233 
180 min was lower following both breakfast meals (CHO+WP, 0.13 ± 0.03 mmol/L; CHO, 0.13 ± 0.03 234 
mmol/L) compared to NB (0.44 ± 0.08 mmol/L; p < 0.05; Table 2), however triglyceride (CHO+WP, 0.77 235 
± 0.13 mmol/L; CHO, 0.67 ± 0.07 mmol/L; NB, 0.66 ± 0.07 mmol/L; p = 0.334) and glycerol (CHO+WP, 236 
37 ± 7 µmol/L; CHO, 41 ± 5 µmol/L; NB, 57 ± 9 µmol/L; p = 0.092; Table 2) responses were not different 237 
between trials.   238 
 239 
 240 
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Figure 3. Mean ± SEM temporal changes in plasma triglyceride (a), NEFA (b) and glycerol (c) during the post 242 
breakfast period, and plasma triglyceride (d), NEFA (e) and glycerol (f) during the post lunch period. Significant 243 
differences (p < 0.05) between trials at individual time points are defined as follows; *NB vs CHO+WP and CHO, 244 
** NB vs CHO+WP. CHO: high carbohydrate breakfast trial; CHO+WP: high-carbohydrate breakfast with added 245 
whey protein trial; NB: no breakfast trial. 246 
 247 
 248 
 249 
 250 
 251 
 252 
 253 
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Table 2. Time-averaged areas under the curve for blood and plasma variables during post breakfast 254 
and post lunch postprandial periods. 255 
  CHO+WP 1, 2 CHO NB 
           
Glucose (mmol/L)           
Post breakfast 
AUC 3.8 ± 0.2 4.2 ± 0.2 4.2 ± 0.1 
iAUC -0.4 ± 0.1 -0.2 ± 0.1 -0.2 ± 0.1 
Post lunch AUC 4.1 ± 0.1 4.0 ± 0.1 4.1 ± 0.2 
iAUC 0.4 ± 0.2 -0.0 ± 0.1 -0.1 ± 0.2 
Insulin (pmol/L)           
Post breakfast 
AUC 193.1 ± 26.3a 154.7 ± 18.5b 46.1 ± 8.0c 
iAUC 120.2 ± 15.3a 83.5 ± 8.6b -8.2 ± 2.8c 
Post lunch AUC 130.7 ± 18.8 136.9 ± 15.7 110.8 ± 18.6 
iAUC 70.8 ± 11.1 74.2 ± 9.4 68.9 ± 13.5 
Triglyceride (mmol/L)           
Post breakfast 
AUC 0.77 ± 0.13 0.67 ± 0.07 0.66 ± 0.07 
iAUC -0.02 ± 0.03 0.00 ± 0.02 -0.04 ± 0.02 
Post lunch AUC 1.16 ± 0.16
a 0.99 ± 0.11a 0.82 ± 0.10b 
iAUC 0.42 ± 0.05a 0.39 ± 0.04a 0.18 ± 0.05b 
NEFA (mmol/L)           
Post breakfast 
AUC 0.13 ± 0.03a 0.13 ± 0.03a 0.44 ± 0.08b 
iAUC -0.42 ± 0.13 -0.35 ± 0.11 -0.08 ± 0.05 
Post lunch AUC 0.13 ± 0.02
a 0.18 ± 0.02 0.21 ± 0.02b 
iAUC 0.02 ± 0.02a 0.01 ± 0.03a -0.35 ± 0.08b 
Glycerol (µmol/L)           
Post breakfast 
AUC 37 ± 7 41 ± 5 57 ± 9 
iAUC -34 ± 15 -30 ± 8 -4 ± 4 
Post lunch AUC 37 ± 6 45 ± 3 40 ± 7 
iAUC -9 ± 4 -5 ± 6 -26 ± 13 
           
1 Values presented as mean ± SEM; 2 Labelled values with different lowercase letters on the same 256 
row are significantly different between trials, p < 0.05. CHO: high carbohydrate breakfast trial; 257 
CHO+WP: high-carbohydrate breakfast with added whey protein trial; iAUC: net incremental 258 
area under the curve; NB: no breakfast trial 259 
 260 
Temporal changes in subjective appetite following breakfast consumption are indicated by 261 
incremental time course responses for combined appetite scores (Figure 4a). There was a significant 262 
condition x time interaction (p < 0.001), condition effect (p < 0.001) and time effect (p < 0.001). 263 
Combined appetite scores were suppressed similarly under CHO+WP and CHO, with change from 264 
baseline under both remaining below NB from 30-120 minutes post breakfast (p < 0.05). Time-265 
averaged iAUC0-180 min for combined appetite score was greater under NB in comparison to CHO+WP 266 
and CHO (p < 0.05; Table 3), with similar suppression observed under both breakfast trials (p > 0.05). 267 
This observation is replicated for feelings of hunger, whilst prospective consumption iAUC0-180 min was 268 
greater under NB in comparison to CHO+WP only (p = 0.004; Table 3). 269 
 270 
Journal 2015, volume, page–page 
9 
 271 
Figure 4. Mean ± SEM delta baseline changes in combined appetite score during the post breakfast (a) and post 272 
lunch (b) periods. Significant differences (p < 0.05) between trials at individual time points are defined as follows; 273 
*NB vs CHO+WP and CHO, **NB vs CHO+WP. CHO: high carbohydrate breakfast trial; CHO+WP: high-274 
carbohydrate breakfast with added whey protein trial; NB: no breakfast trial. 275 
 276 
 277 
 278 
 279 
 280 
 281 
 282 
 283 
 284 
 285 
 286 
 287 
 288 
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Table 3. Time-averaged areas under the curve for subjective appetite variables during post breakfast and post 290 
lunch postprandial periods 291 
  CHO+WP 1, 2 CHO NB 
           
Combined appetite score (mm)           
Post breakfast 
AUC 53.0 ± 3.9a 55.4 ± 4.6a 82.1 ± 2.5b 
iAUC -23.1 ± 4.5a -18.4 ± 5.7a 8.3 ± 0.8b 
Post lunch AUC 52.2 ± 4.8 57.4 ± 5.2 61.0 ± 5.7 
iAUC -16.4 ± 4.4 -16.5 ± 3.5 -28.2 ± 5.9 
Hunger (mm)           
Post breakfast 
AUC 48.7 ± 3.8a 52.5 ± 4.3a 74.5 ± 3.2b 
iAUC -24.1 ± 4.4a -16.8 ± 5.7a 9.8 ± 2.1b 
Post lunch AUC 48.7 ± 4.7 54.8 ± 5.0 57.3 ± 5.4 
iAUC -16.4 ± 4.6 -17.0 ± 3.8 -26.7 ± 5.7 
Fullness (mm)           
Post breakfast 
AUC 47.6 ± 4.0a 46.1 ± 4.6a 15.9 ± 2.4b 
iAUC 25.9 ± 4.7a 23.1 ± 5.1a -8.9 ± 1.6b 
Post lunch AUC 49.2 ± 4.5 43.9 ± 5.5 39.2 ± 5.7 
iAUC 17.3 ± 4.8a 17.8 ± 3.4 30.8 ± 6.2b 
Prospective Consumption (mm)           
Post breakfast 
AUC 58.1 ± 5.0a 60.4 ± 6.0a 85.0 ± 2.4b 
iAUC -19.4 ± 5.0a -13.1 ± 7.3 6.8 ± 1.2b 
Post lunch AUC 56.8 ± 6.3 62.0 ± 5.7 65.4 ± 6.4 
iAUC -15.6 ± 4.6 -14.3 ± 3.9 -24.0 ± 6.4 
Satisfaction (mm)           
Post breakfast 
AUC 47.1 ± 3.5a 45.4 ± 4.3a 15.4 ± 2.5b 
iAUC 23.1 ± 5.0a 20.7 ± 5.1a -7.8 ± 1.7b 
Post lunch AUC 47.6 ± 4.1 43.2 ± 5.1 39.7 ± 5.5 
iAUC 16.1 ± 4.8 16.8 ± 3.5 31.1 ± 5.7 
           
1 Values presented as mean ± SEM; 2 Labelled values with different lowercase letters on the same 292 
row are significantly different between trials, p < 0.05. CHO: high carbohydrate breakfast trial; 293 
CHO+WP: high-carbohydrate breakfast with added whey protein trial; iAUC: net incremental 294 
area under the curve; NB: no breakfast trial. 295 
 296 
 297 
 298 
3.2 Post Lunch Responses 299 
 300 
Following lunch insulinaemic and glycaemic responses were not significantly different across all 301 
trials (Figure 2c-d). There was no effect of condition or time x condition interaction on plasma insulin 302 
or blood glucose concentrations (p > 0.05). Postprandial time-averaged AUC also indicated that 303 
insulinaemia (CHO+WP, 130.7 ± 18.8 pmol/L; CHO, 136.9 ± 15.7 pmol/L; NB, 110.8 ± 18.6 pmol/L; p = 304 
0.283) and glycaemia (CHO+WP, 4.1 ± 0.1 mmol/L; CHO, 4.0 ± 0.1 mmol/L; NB, 4.1 ± 0.2 mmol/L; p = 305 
0.509; Table 2) were not different throughout the 180 minute period following consumption of a 306 
subsequent meal.  307 
Plasma triglyceride concentrations were elevated above NB responses under CHO and CHO+WP 308 
at 90-150 minutes post lunch (p < 0.05; Figure 3d). In contrast, no significantly different responses 309 
were observed between trials for NEFA from 45-180 minutes post lunch (p > 0.05; Figure 3e), with no 310 
differences in plasma glycerol concentrations between trials throughout (p > 0.05; Figure 3f).  311 
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Deviations in subjective appetite responses between CHO+WP and CHO were not found 312 
following lunch (p > 0.05; Figure 4b). Indeed, time-averaged iAUC was not different between all 313 
conditions for combined appetite score, in addition to the component measures of hunger, 314 
prospective consumption and satisfaction (p > 0.05; Table 3). Post lunch fullness iAUC was greater 315 
under NB than CHO+WP (p = 0.045), indicating more positive perception of this measure following 316 
prior breakfast omission (Table 3).  317 
 318 
4. Discussion 319 
The aim of this study was to investigate the effect of supplementing a carbohydrate breakfast with 320 
whey protein on metabolic and appetite responses acutely and following a subsequent meal. The 321 
study was designed to reflect practical application in a free-living setting; the amount of whey, the 322 
timing of supplementation and composition of meals were realistically achievable in the context of 323 
habitual eating habits. We show that adding 20 g of whey protein to breakfast increases the acute 324 
insulin response, without influencing glycaemia, lipaemia or appetite sensations compared to an 325 
identical meal without additional whey in young healthy males. For the first time we show that 326 
adding 20 g of whey protein to breakfast does not alter glycaemic, insulinaemic and appetite 327 
responses to a subsequent lunch meal, compared to breakfast without whey, or fasting, in young 328 
males free from metabolic disease.  329 
Our observation of increased circulating insulin with whey protein supplementation reflects the 330 
effect observed in a number of studies [7,8,15]. Potential mechanisms may centre on the amino acid 331 
profile of whey itself, and its consequent incretin hormone stimulatory properties [20]. Whilst we 332 
detected a ~25% increase in post breakfast (0-180 min) insulin AUC with the addition of whey to a 333 
carbohydrate breakfast, this did not augment a significant effect on postprandial blood glucose. This 334 
is contrary to the findings of previous studies, where various doses of whey protein have elicited 335 
positive effects on acute glycaemia in both healthy [7,33] and diabetic [5,22] populations. This may 336 
partly be explained by insulin resistance being greater early in the morning following an overnight 337 
fast [34], suggesting that the insulinotrophic effect was not strong enough to offset this. Whey protein 338 
ingestion has also been shown to induce acute insulin resistance through impaired glucose disposal at 339 
whole body level and across the leg [35], albeit in obese post-menopausal female participants. Whilst 340 
the mechanisms responsible for such an observation remain unclear, it is likely that any effects are 341 
counterbalanced by the promotion of insulin secretion by protein ingestion. Whereas, it is possible the 342 
dose of whey protein was insufficient to elicit a significant reduction in glycaemia in healthy males, 343 
the efficacious dose to affect insulin and post-meal glycaemic response is reported to be as low as 10 g 344 
in healthy individuals [4]. Following lunch, both glycaemia and insulinaemia were not affected by 345 
prior whey consumption, indicating the priming effect of elevated pre-lunch insulin on pancreatic 346 
beta cells may not have been substantial enough to alter post lunch metabolism [36]. 347 
In the present study, whey protein supplementation did not affect subjective appetite. A number 348 
of studies have previously reported no effect of whey protein consumption on satiety and subsequent 349 
energy intake [37,38]. This is in contrast to other published observations, where consumption of whey 350 
has enhanced satiety through a variety of proposed mechanisms, including increases in peak amino 351 
acid, GLP-1 and cholecystokinin (CCK) concentrations in healthy females [9,39]. As energy intake was 352 
not measured in the current study, it is difficult to infer any direct effect that these sensations may 353 
have on subsequent intake [40]. 354 
Cross-sectional studies have associated regular breakfast consumption with improved health 355 
outcomes such as lower BMI and improved glycaemic control [41,42], however few randomised trials 356 
exist to support the causality of such associations, with recent studies suggesting no effect of breakfast 357 
consumption on weight loss [43,44]. In the current study, breakfast omission did not affect 358 
postprandial glucose or insulin concentrations following lunch. With regards to satiety, participants 359 
felt fuller (relative to baseline) following lunch after prior breakfast omission compared to after the 360 
whey protein supplemented breakfast. This is surprising as breakfast omission has previously been 361 
shown to negatively affect satiety responses to foods later in the day, with [45] or without [46] 362 
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subsequent increases in energy intake. The fact that participants were significantly less full at the 363 
lunch period baseline (180 min post breakfast) after breakfast omission meant that although the 364 
change in fullness from baseline was greater, this did not represent an absolute feeling of greater 365 
fullness. Breakfast omission did not significantly affect any of the other subjective appetite indices in 366 
the post lunch period and similar circulating concentrations of insulin, which is considered a satiety 367 
hormone [47], reflected this. Further research is required to establish whether participants would 368 
overcompensate in terms of energy intake at a following meal regardless of subjective appetite 369 
ratings. 370 
Measures of postprandial lipaemia were similar between both breakfast trials throughout, 371 
however the omission of breakfast appeared to impact on post meal lipid metabolism. NEFA was 372 
significantly higher following breakfast omission, an effect that is likely mediated by the antilipolytic 373 
action of insulin released in response to breakfast [48], and returned to similar levels to both breakfast 374 
trials 45 minutes after lunch. Elevated NEFA levels have previously been linked to metabolic 375 
dysregulation and cardiovascular disease risk[49] however, conversely, it has also been argued that 376 
they are not necessarily associated with insulin resistance [50]. Plasma triglyceride concentrations 377 
were significantly lower 90-150 minutes post lunch following breakfast omission. It may have been 378 
concluded that such a finding is related to the appearance of triglyceride in the plasma following 379 
prior breakfast consumption [50], however the very low fat content of the breakfast (2 g) would 380 
suggest that the handling of dietary fat from lunch (33 g) was affected by breakfast omission. As 381 
insulin concentrations were not significantly different across conditions post lunch, this suggests the 382 
reduction in plasma triglyceride concentration was not mediated by insulin-stimulated lipoprotein 383 
lipase activity. This reduction may have implications when considering the current swathe of public 384 
opinion suggesting that breakfast is the most important meal of the day. Our findings suggest that 385 
skipping breakfast on a single occasion may not be detrimental to the response to foods consumed 386 
later that day, and may provide beneficial effects on plasma triglyceride profile and, as mentioned 387 
above, subjective sensations of fullness. Whether subsequent energy intake would be influenced 388 
remains to be established, however recent data indicates that the frequency, timing and composition 389 
of meals consumed later in the day are not different during 6 weeks of breakfast omission compared 390 
to regular breakfast consumption [43]. Metabolic responses in the longer term are still unclear 391 
however, with such behaviour potentially leading to lower essential nutrient intakes over time. 392 
The primary findings of the current study are contrary to the body of evidence which suggests 393 
whey protein can provide acute advantages in postprandial handling of meals. There is a clear need 394 
for studies investigating the effects of whey protein consumption at multiple meals so that findings 395 
can be applied to a real world setting. Research has focused on the effects of prior meal composition 396 
on responses to a subsequent meal, often termed the ‘second meal effect’ [46,51,52]. In the present 397 
study glycaemia was not significantly different across trials following lunch. Chronic 398 
supplementation may be more efficacious when the aim is to positively affect the postprandial milieu 399 
throughout the day, particularly as individuals spend the majority of the day in the postprandial state 400 
[13]. Further research is also required to fully ascertain whether whey supplementation confers 401 
beneficial effects on metabolic responses. Acutely, the promotion of greater insulin secretion 402 
following whey protein consumption may have a glucose lowering effect [7,8,15]. Chronically 403 
however, prolonged hyperinsulinaemia in normoglycaemic conditions may decrease insulin 404 
sensitivity [53]. The acute increase in circulating insulin observed in the present study may therefore 405 
be of benefit to individuals with type 2 diabetes, however the chronic effects in healthy, insulin 406 
sensitive individuals is less clear.  407 
The breakfasts provided in the present study were not matched for energy content, and this may 408 
limit the validity of direct comparisons between each meal. This was a consequence however, of the 409 
effort to ensure that this experimental manipulation had practical application, in an effort to mimic 410 
the effect of ‘adding’ a supplement to a meal, rather than replacing or substituting different 411 
components of a meal.  412 
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In summary, we implemented an ecologically valid protocol to assess the effect of supplementing 413 
a carbohydrate-rich breakfast with whey protein on metabolic and appetite responses, acutely and 414 
following a subsequent meal. Whey protein addition to breakfast increased the insulinaemic response 415 
to that meal, without influencing metabolic or appetite responses to a subsequent mixed-416 
macronutrient lunch. Breakfast omission induced glycaemic, insulinaemic and combined appetite 417 
responses to a subsequent meal that did not differ from breakfast consumption, while maintaining 418 
lower circulating triglyceride concentrations.  419 
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